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Genetically engineered mice with targeted mutations in genes encoding immunologically relevant molecules were used
to elucidate the role of different immune effector mechanisms in protection against a rabies virus (RV) infection. In vaccinated
animals challenged with a highly virulent strain of RV, antibodies were crucial in protection. In naive mice challenged with
an attenuated strain of the virus that does not cause disease in adult fully immunocompetent mice but kills RAG mice that
lack functionally active T and B cells, different immune effector mechanisms were shown to suffice for protection.
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INTRODUCTION either peripherally into muscle tissue or directly intrace-
rebrally (ic) into the brain (Dietzschold and Ertl, 1991).
Rabies virus (RV),4 a member of the Rhabdoviridiae
Adoptive transfer of monoclonal antibodies to the RV G
family of the Lyssavirus genus, is a bullet-shaped, nega-
protein was also shown to fully protect against a periph-
tive-stranded RNA virus composed of five structural pro- eral challenge with RV, although they provided only mar-
teins, the viral glycoprotein (G protein) that forms trimers ginal protection against a challenge given directly into
on the surface of the virion, the membrane protein, and the central nervous system (Dietzschold and Ertl, 1991;
the three internal proteins, the nucleoprotein (N protein), Schumacher et al., 1989). The N protein induces a strong
the nominal phosphoprotein (NS protein), and the viral T helper cell response as well as nonneutralizing anti-
polymerase, that are tightly complexed with the viral ge- bodies (Ertl et al., 1989). Animals vaccinated with N pro-
nome forming the ribonucleoprotein complex. Upon in- tein vaccines were shown to be protected against a pe-
fection that is commonly caused by the bite of a rabid ripheral challenge with RV but succumbed upon inocula-
animal, the virus rapidly enters the nervous system even- tion of the virus into the central nervous system (Fu et
tually causing a nearly always fatal encephalitis. The al., 1991). The NS protein of RV induces an excellent
immune responses to some of the viral proteins and cytolytic T cell response in some mouse strains but fails
their ability to provide protective immunity when used as to stimulate a strong T helper or B cell response (Larson
subunit vaccines have been studied in depth. The RV G et al., 1992). Mice vaccinated with a recombinant vaccinia
protein presented either by a viral recombinant (Wiktor virus expressing the NS protein were not protected
et al., 1984) or a DNA vaccine (Xiang et al., 1994) induces against challenge with RV (Larson et al., 1992), indicating
a full spectrum of immune responses including neutraliz- that cytolytic T cells were insufficient to limit the spread
ing antibodies, T helper cells, and cytolytic T cells. Ani- of this virus.
mals immunized with subunit vaccines based on the G The data briefly summarized above suggest that neu-
protein are fully protected against viral challenge given tralizing antibodies play a major role in preventing a fatal
RV infection at least upon peripheral challenge, presum-
ably by preventing the virus from entering the central1 Current address: The Jackson Laboratory, Bar Harbor, Maine.
2 Current address: Department of Ob/Gyn, University of California, nervous system (Shankar et al., 1991). The role of T cells,
San Francisco, California. especially cytokine-releasing T helper cells, could not
3 To whom reprint requests should be addressed. Fax: (215) 898- be established by these data. To further investigate the
3868.
contribution of humoral versus cellular immunity in lim-4 Abbreviations used: G protein, glycoprotein; N protein, nucleopro-
iting the spread of RV either from the periphery into thetein; NS, nominal phosphoprotein; BHK, baby hamster kidney; ERA,
Evelyn Rokitniki Abelseth; BPL, b-propionolactone; CVS, challenge vi- nervous system or within the central nervous system, we
rus standard; VRG, vaccinia rabies glycoprotein; VNA, virus-neutralizing tested in the present study the effect of vaccination on
antibody; ic, intracerebrally; 10 LD50 , 10 mean lethal doses; DMEM, challenge with a virulent strain of RV using a number of
Dulbecco’s minimal essential medium; FBS, fetal bovine serum; sc,
well-characterized genetically engineered mice that aresubcutaneously; RV, rabies virus; PFU, plaque forming units; MHC,
deficient in defined immune effector functions. Further-major histocompatibility complex; FITC, fluorescein isothiocyanate; im,
intramuscularly. more, to gain information on the role of different arms of
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the immune system during a primary infection in naive responses and the generation of antibodies of the IgG1,
IgE, and IgA isotypes. In some viral diseases such asanimals, an attenuated RV strain termed 194.2 (Dietz-
schold et al., 1983) that is readily controlled by adult in childhood infections with respiratory syncicial virus,
vaccines favoring Th2-type responses were shown toimmunocompetent mice was tested in different knock-
out mouse strains. exacerbate disease (B. S. Graham et al., 1993). Vaccines
to RV tested so far induce a Th1 rather than a Th2-type
response (Ertl, unpublished observation). The effect of aMATERIALS AND METHODS
Th2-type immune response on RV challenge remains to
Animals
be investigated.
All of the knock-out mice were generated by introduc-Female C57BL/6 and 129/J mice were purchased from
The Jackson Laboratory (Bar Habor, ME). Outbred ICR ing defects into ES cells derived from 129 mice that were
then transferred into C57BL/6 blastocyst. Both of thesemice were purchased from Harlan Sprague–Dawley (In-
dianapolis, IN). Genetically engineered mice were bred mouse strains, i.e., 129 and C57BL/6 mice carry the H-2b
haplotype but are otherwise genetically distinct. C57BL/6at the Animal Facility of The Wistar Institute. The follow-
ing mice were used: mice are low B cell responders to RV vaccines while 129
mice develop higher antibody titers comparable to thoseRAG1 (Mombaerts et al., 1992) mice similar to RAG2
mice have defects in the genes encoding recombinases of other mouse strains (unpublished observation). Al-
though some of the knock-out mouse strains such theneeded for recombination of functionally active immuno-
globulin or T cell receptor genes. These mice thus show GKO mice were backcrossed for several generations
onto the C57BL/6 background, others such as the CD4m3a complete lack of antigen-specific B or T cells. CD4m3
mice that lack CD4/ T cells were generated using a mice were segregating B6 and 129 alleles. Throughout
most of our studies, mice of both parental strains, i.e.,novel diphtheria toxin A-chain positive–negative selec-
tion system (McCarrick et al., 1993). Targeted CCE cells C57BL/6 and 129, were thus used as controls.
Mice were maintained at the Animal Colony at The Wistarwere injected into C57BL/6J blastocysts and chimeric
mice were interbred. Those homozygous for the intro- Institute and used between 8 and 12 weeks of age.
duced mutation were identified by a lack of staining of
Cellstheir peripheral blood lymphocytes with an fluorescein
isothiocynate (FITC)-labeled anti-mouse CD4 antibody.
Baby hamster kidney (BHK)-21 cells, C57SV mouse
The CD4m3 mice fail to generate CD4/, MHC class II-
embryonic cells, and HeLa cells were maintained in Dul-
restricted T helper cells affecting their ability to mount
becco’s minimal essential medium (DMEM) supple-
antibody responses to antigenic challenge. Due to an
mented with 10% fetal bovine serum (FBS), HEPES buffer,
alternative CD4 independent pathway (Locksley et al.,
and antibiotics in a 10% CO2 incubator. HT-2 cells, that1993) these mice can generate an, albeit low, antibody
proliferate in response to IL-2 and IL-4, were grown in
response. mMT mice (Kitamura and Rajewsky, 1991)
DMEM supplemented with 10% fetal calf serum 1006 M
were generated by inducing a defect into the transmem-
2-mercaptoethanol and 10% rat concanavalin A superna-
brane domain of the immunoglobulin transmembrane
tant. CT4S cells, that grow only in presence of IL-4 (Hu-
exon. These mice that have abnormally small spleens
Li et al., 1989), were grown in DMEM without HEPES
show a complete lack of B cell responses. b2 knock-out
buffer supplemented with 10% FBS, and 10 units of re-
mice (Zijlstra et al., 1990) lack b2-microglobin, a protein combinant murine IL-4 per milliliter.
needed for cell surface expression of MHC class I mole-
cules. These mice consequently lack CD8/ MHC class Viruses
I-restricted T cells that are the main T cell subset capable
of mediating antigen-specific cell lysis. GKO mice (Dalton RV of the Evelyn Rokitniki Abelseth (ERA) strain was
propagated on BHK-21 cells, purified, and inactivatedet al., 1993) lack expression of interferon-g, a cytokine
known to have antiviral activity. This cytokine, further- with b-propionolactone (BPL, inactivated ERA: ERA-BPL)
as described previously (Wiktor, 1973). The RV 194.2more, upreguates expression of MHC determinants on
numerous cells including neurons (Neumann et al., strain, that due to a single point mutation affecting the
arginine at position 333 of the G protein (Dietzschold et1995). GKO mice have been shown to respond to infec-
tion with influenza virus with a Th2 rather than the Th1 al., 1983) has lost virulence for adult mice but still causes
disease upon intracerebral inoculation into neonates,response exhibited by fully immunocompetent mice
(M. B. Graham et al., 1993). T helper cells of the Th1 type was propagated and titrated on BHK-21 cells. The chal-
lenge virus standard (CVS)-24 strain of RV, that is anti-secrete predominantly IL-2 and interferon-g and provide
help to cytolytic T cells and sponsor the development of genically closely related to the ERA strain but shows
higher virulence in mice, was derived from brain suspen-antibodies of the IgG2a isotype. Th2 cells, on the other
hand, secrete IL-4, -5, and -10 and facilitate inflammatory sions of infected newborn ICR mice (Wiktor et al., 1977).
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The CVS-11 strain was grown on BHK-21 cells. The vac- kit) diluted in PBS. Rabbit anti-mouse IgG isotype (100
ml/well) was added for 1 hr at room temperature. Platescinia rabies glycoprotein (VRG) virus was propagated on
HeLa cells. were washed and a dilution of goat anti-rabbit IgG conju-
gated to peroxidase was added for 1 hr at room tempera-
Immunization and infection of mice ture. Plates were washed and 100 ml of 3,3*, 5,5*tet-
ramethyl-9-benzidine substrate was added. After 5 min
Groups of mice were injected subcutaneously (sc) three
at room temperature, 50 ml of 1 M phosphoric acid was
times with 106 plaque-forming units (PFU) of VRG virus.
added. Optical density was determined at 450 nm.
ERA-BPL virus was given sc at 2 mg per mouse. Mice were
bled by retro-orbital puncture to assess serum antibody Lymphokine release assay
titers. Mice were challenged with 10 mean lethal doses
Splenocytes from immunized mice were cultured at 6(LD50) of CVS-24 virus given intramuscularly (im) into the
1 106 cells per well in 24-well Costar plates in 1.6 mlmasseter muscle or with 104 PFU (104 PFU are the equiva-
DMEM supplemented with 2% FBS and 1006 2-mercapto-lent of 10 LD50) of CVS-11 virus given directly into the brain.
ethanol with or without addition of 250 ml of ERA-BPLThe RV 194.2 virus was given ic at 104 PFU. Infected mice
virus diluted to 5 mg of virus per milliliter. Cell-free super-were observed for the following 3 weeks (CVS virus) or 3
natants were harvested 24 hr later. HT-2 (2 1 103) ormonths (RV 194.2 virus) for symptoms indicative of a RV
CT4S (2 1 103) cells were cocultured with an equal vol-infection. Mice that developed complete bilateral hindleg
ume of the culture supernatants in 96-well round-bottomparalysis (proceeding death by 24–48 hr) were euthanized
microtiter plate wells. Proliferation of the indicator cellsfor humanitarian reasons.
was assessed 48–72 hr later by a 6-hr pulse with 0.5
Isolation of virus from brain suspensions mCi of [3H]thymidine (Ertl et al., 1991).
Terminally ill mice were euthanized by inhalation of
RESULTSCO2 . The entire brain was removed aseptically, freeze –
thawed twice, homogenized in serum-free medium, and To address the role of different immune effector mech-
passaged 5–7 times on BHK-21 cells. Fresh BHK-21 cells anisms in limiting the spread of RV, we used well-defined
were infected with the tissue culture adapted virus for 2 knock-out mouse strains that, due to introduced germ
days and stained with an FITC-labeled antibody to the line gene defects, lack certain immune effector functions.
RV nucleoprotein.
Protective immunity to challenge with a virulent strain
Antibody neutralization assay of RV in vaccinated mice
Blood samples were obtained by retro-orbital punc- In the initial experiments, mice were vaccinated three
ture. Sera were prepared, heat-inactivated, batched, and times, at 14-day intervals with 106 PFU of VRG virus. Mice
stored at 0207. Virus-neutralizing antibody (VNA) titers were bled after the third immunization and VNA titers
were determined on BHK-21 cells using infectious ERA were determined from sera. Mice were subsequently
virus at 1 PFU per cell (Ertl et al., 1989). Data are ex- challenged with 10 LD50 of the CVS strain of RV given
pressed as neutralization titers which are the reciprocal either into the masseter muscle or directly into the cere-
of the serum dilution resulting in a 50% reduction in the brum. Protection upon peripheral as well as ic challenge
number of infected cells. Samples were assayed in dupli- clearly correlated with VNA titers. Strikingly, mMT mice
cate in serial threefold dilutions starting with a dilution that failed to generate any antibodies to RV died upon
of 1:5. Standard deviations were within 10% for any given challenge, and CD4m3 mice that developed low but mea-
experiment. surable antibody titers showed partial protection (Table
1). All of the other mouse strains had the same low mor-
Enzyme-linked immunoadsorbent assay (ELISA) tality rates as the control mice indicating that neither
cytolytic T cells (missing in b20 mice) or interferon-gThe isotypes of antibodies to RV induced by the VRG
(absent in GKO) mice are required for protection againstor the 194.2 virus were determined by an ELISA using
RV in vaccinated animals.the Calbiochem (San Diego, CA) hybridoma subisotyping
kit according to the manufacturer’s suggestions with Protective immunity to challenge with an attenuated
some minor modifications. Nunc II plates were coated strain of RV in naive mice
with 0.2 mg of purified inactivated ERA virus and then
blotted with a 2% BSA solution as described (Xiang and The mechanisms that limit the spread of RV during infec-
tion with a sublethal dose in unvaccinated animals mightErtl, 1992). A 1:300 dilution of sera was added (100 ml/
well) in duplicates for 1 hr at room temperature. Plates differ from those that prevent disease to a lethal challenge
in vaccinated animals. We conducted a limited set of experi-were washed with surfactant (provided with the isotyping
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TABLE 1 cocultured with supernatants of tissue-culture-adapted vi-
rus initially derived from the RAG1 brains showed strongThe Role of Different Immune Effector Mechanisms in Limiting the
staining with increasing percentages of positive cells fol-Spread of Virulent Rabies Virus in Vaccinated Mice
lowing each additional in vitro passage while cells cultured
Mortality with supernatants from control brains were negative.
Mouse Most of the mice from other knock-out mouse strains
strain im challenge ic challenge VNA titer
survived challenge with the attenuated virus. No virus could
be isolated from the brains of the surviving mice euthanizedC57BL/6 1/11 (9) 3/19 (16) 1:405
129 nt 2/14 (14) n.t. 3 months after challenge, thus indicating that the virus had
mMT 8/8 (100) 14/14 (100) 0 been cleared from the central nervous system presumably
mb2 1/6 (17) 2/14 (14) 1:405 by immunological effector mechanisms. One of a group of
CD4m3 3/6 (50) 9/15 (60) 1:45
eight mMT mice and two of eight b20 mice succumbed toGKO nt 0/4 (0) 1:300
the infection. There was no correlation with antibody titers
Note. Mice were immunized three times with VRG virus. Serum anti- tested 8 weeks after challenge in surviving mice;mMT mice
body titers (VNA) were determined 10 days after the third immunization. failed to develop antibodies; GKO and CD4m3O mice devel-
Mice were then challenged with 10 LD50 of CVS-24 virus given im or oped low titers compared to b20 mice or immunocompe-
of CVS-11 virus given ic. The experiments summarize the results of
tent control mice. Together these data indicate that otherfour separate challenge experiments. The VNA titers are given for one
immune effector mechanisms in addition to antibodies suchof the experiments. n.t., not tested.
as MHC class I-restricted cytolytic T cells may play a role
in limiting the spread of the 194.2 virus. Similar mechanisms
might control the growth of a virulent strain of RV given atments inoculating mice with varied doses of infectious virus
to test if the knock-out mouse strains differed in their sus- a sublethal dose.
ceptibility to viral challenge. No striking difference in sus-
Characterization of the immune response to the viralceptibility could be observed (RAG1 mice were not included
vaccine or to the attenuated RV with regard to the Tinto this experiment). To further address the question of
helper cell pathwaythe role of different immune effector mechanisms during a
primary infection of the central nervous system with RV, we To test if the genetic defect in the knock-out mice affects
used a viral mutant, the 194.2 variant strain of CVS virus the type of the T helper cell response upon infection with
that, due to a single point mutation of the G protein, has attenuated virus, mice were euthanized 3 months after in-
lost virulence in adult mice (Dietzschold et al., 1983). This fection, and their splenocytes were tested for cytokine re-
virus causes a lethal infection in newborn mice, and it lease upon restimulation with inactivated RV in vitro. As
induces, upon infection of adult mice, an inflammatory reac- shown in Fig. 1, all of the mouse strains tested except the
tion in the central nervous system indicating that an im- CD4m3 mice secreted cytokines that induced proliferation
mune response limits the spread of this attenuated virus. of the HT-2 cells, an indicator cell line that grows upon
Adult knock-out mice as well as control mice were inocu- coculture with either IL-2 or IL-4. None of the culture super-
lated ic with the 194.2 virus (Table 2). All but one of the natants induced proliferation of CT4S cells, another indica-
RAG1 mice developed symptoms and eventually died (or tor cell line that responds exclusively to IL-4. Similar results
were euthanized for humanitarian reasons) thus confirming were obtained from splenocytes of knock-out mice vacci-
that the spread of the 194.2 virus was controlled by a spe- nated with an inactivated RV vaccine (data not shown). In
cific immune response. The disease pattern in RAG1 mice
upon infection with 194.2 virus was clearly distinct from
TABLE 2that seen upon challenge with virulent RV, that occurs in
immunocompetent as well as in immunodeficient mice, The Role of Different Immune Effector Mechanisms in Limiting the
and includes wasting symptoms 7–8 days after infection, Spread of Attenuated Rabies Virus in Naive Mice
hindleg weakness approximately 1 day later, then complete
Mouse strain Mortality VNA titershindleg paralysis, and death. RAG1 mice challenged with
194.2 virus developed symptoms after 4–8 weeks and
C57BL/6 0/10 (0) 1:1215
showed a procrastinated disease for 7–10 days. To ensure RAG1 17/18 (94) nt
that the symptoms were related to the presence of RV, mMT 1/8 (12) 1:5
mb2 2/8 (25) 1:135three of the moribund RAG1 mice as well as some naive
CD4m3 0/8 (0) 1:45control mice were euthanized and their brains were har-
GKO 0/7 (0) 1:15vested. Suspensions thereof were cocultured with BHK-21
cells. After several passages the cells were stained for the Note. Mice were injected with 194.2 virus ic. Mice died between 3
presence of RV by direct immunofluorescence using an and 8 weeks after infection. VNA titers were determined from surviving
mice 2 months after viral challenge. nt, not determined.FITC-labeled antibody to the RV nucleoprotein. BHK-21 cells
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FIG. 1. Mice were immunized with 194.2 virus ic. Splenocytes were harvested 2 months later and cocultured with medium (j) or 5 mg/ml of ERA-
BPL virus (‰). Cell-free 24 hr supernatants were tested on HT-2 or CT4S indicator cells.
addition, serum antibodies from mice immunized with either rather than the magnitude of the immune response play
distinct roles in providing protection to RV. In VRG-vacci-VRG or the 194.2 strain of RV were isotyped for IgG1, IgG2b
indicative for a Th2-type response and IgG2a suggestive nated mice, those that lacked CD4 T cells had a clearly
distinct isotype profile compared to the other mousefor a Th1-type immune response. As shown in Fig. 2, all of
the knock-out strains as well as the C57BL/6 mice that strains that were fully protected. Nevertheless, these
mice also had significantly lower antibody titers to RVwere injected with 194.2 virus directly into the central ner-
vous system developed high levels of IgG2b antibodies to upon vaccination when compared to the other mouse
strains (Table 1). In 194.2-infected mice, a small percent-RV. All of the mice had comparable low levels of IgG1.
Levels of IgG2a antibodies differed between the strains; age of mb2 mice succumbed to the infection while all of
the CD4m3 mice survived (Table 2). Both mouse strainsGKO and C57BL/6 mice had less IgG2a compared to IgG1.
b2 knockout and CD4m3 mice had comparatively more showed nearly identical isotype patterns, suggesting that
Th1-type versus Th2-type responses and the correspond-IgG2a. The response to VRG was similar in GKO and
C57BL/6 mice that showed a predominant IgG2b response, ing cytokines and antibody isotype were not a crucial
factor in determining susceptibility to the 194.2 virus.a strong IgG1 response, and low levels of IgG2a. The main
difference was seen in mb2 and CD4m3 mice. The mb2 Taken together, these data suggest that mice, regardless
of their introduced immunological defects, respondedmice did not develop IgG2a to the VRG vaccine but showed
a classical Th2-type profile, while CD4m3 mice mainly de- with a T helper cell response that could not be strictly
classified into a Th1 or Th2 pattern (Kelsoe, 1995).veloped IgG2a and in comparison slightly lower levels of
IgG1 and IgG2b, suggesting support by Th1-type cytokines.
We are currently unable to explain the observed differ- DISCUSSION
ences in the response patterns of the knock-out mouse
strains to the two different immunogens inoculated by RV infection of humans is treated after exposure by a
regimen consisting of passive immunization with hyper-different routes. It is also unclear if the different isotypes
FIG. 2. (A) Mice were injected with 194.2 virus ic. Sera were harvested 2 months later. (B) Mice were injected three times with VRG virus; sera
were harvested 10 day after the last immunization. Isotypes were determined using a 1:300 dilution of serum. Data present the means of duplicate
samples { SD. NMS, serum from unimmune C57B1/6 mice. (j) IgG1, (‰) IgG2a, (É) IgG2b.
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immune serum to RV followed by several doses of an to limit the spread of this virus. The specific immune
response that eliminated the 194.2 virus from the centralinactivated viral vaccine. The hyperimmune serum is par-
tially given around the site of the viral inoculum to neutral- nervous system remains elusive. According to our data
different immune effector mechanisms are likely to con-ize virus particles. Omission of passive immunization
known to interfere with active immunization (Schumacher tribute to the elimination of the virus.
et al., 1992) can result in vaccine failures despite timely
active immunization. The importance of antibodies in pro- ACKNOWLEDGMENTS
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